Home/Filings/4/0001593968-22-001522
4//SEC Filing

Vanhove Geertrui 4

Accession 0001593968-22-001522

CIK 0001824893other

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 6:02 AM ET

Size

20.4 KB

Accession

0001593968-22-001522

Insider Transaction Report

Form 4
Period: 2022-10-10
Vanhove Geertrui
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Option (right to buy)

    2022-10-101,7600 total
    Exercise: $10.77From: 2021-02-01Exp: 2031-02-22Common Stock (1,760 underlying)
  • Award

    Option (right to buy)

    2022-10-10+26,22026,220 total
    Exercise: $2.16From: 2022-08-12Exp: 2031-08-12Common Stock (26,220 underlying)
  • Award

    Option (right to buy)

    2022-10-10+1,7601,760 total
    Exercise: $2.16From: 2021-02-01Exp: 2031-02-22Common Stock (1,760 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2022-10-1024,5870 total
    Exercise: $10.77From: 2021-02-01Exp: 2031-02-22Common Stock (24,587 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2022-10-1010,4270 total
    Exercise: $10.25From: 2022-08-12Exp: 2031-08-12Common Stock (10,427 underlying)
  • Award

    Option (right to buy)

    2022-10-10+24,58724,587 total
    Exercise: $2.16From: 2021-02-01Exp: 2031-02-22Common Stock (24,587 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2022-10-1026,2200 total
    Exercise: $10.25From: 2022-08-12Exp: 2031-08-12Common Stock (26,220 underlying)
  • Award

    Option (right to buy)

    2022-10-10+10,42710,427 total
    Exercise: $2.16From: 2022-08-12Exp: 2031-08-12Common Stock (10,427 underlying)
Footnotes (4)
  • [F1]The reporting person agreed to cancellation of an option granted to her on 2/23/2021, in exchange for a new option having a lower exercise price.
  • [F2]The shares subject to the options vest and become exercisable in a series of 48 equal monthly installments beginning on 2/1/2021, subject to the reporting person's continued employment through the applicable vesting date.
  • [F3]The reporting person agreed to cancellation of an option granted to her on 8/12/2021, in exchange for a new option having a lower exercise price.
  • [F4]Twenty-five percent of the shares subject to the Stock Option vests on 8/12/2022, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Issuer

Surrozen, Inc./DE

CIK 0001824893

Entity typeother

Related Parties

1
  • filerCIK 0001771994

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 6:02 AM ET
Size
20.4 KB